|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ch. 17
|
|
|
|
|
|
2000 LAWS OF MARYLAND
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(II) CONTRACT WITH A HIGHER EDUCATION INSTITUTION OR
PRIVATE ENTITY TO CONDUCT THE BASELINE CANCER STUDY OR ANY PART OF THE
STUDY.
(D) THE BASELINE CANCER STUDY SHALL MEASURE;
(1) THE NUMBER AND PERCENTAGE OF INDIVIDUALS WHO HAVE EACH
TARGETED CANCER, BOTH STATEWIDE AND IN EACH COUNTY;
(2) THE NUMBER AND PERCENTAGE OF INDIVIDUALS WITHIN EACH
MINORITY POPULATION WHO HAVE EACH TARGETED CANCER, BOTH STATEWIDE
AND IN EACH COUNTY;
(3) THE MORTALITY RATE FOR EACH TARGETED CANCER, BOTH
STATEWIDE AND IN EACH COUNTY;
(4) THE MORTALITY RATE FOR DIFFERENT MINORITY POPULATIONS
FOR EACH TARGETED CANCER, BOTH STATEWIDE AND IN EACH COUNTY; AND
(5) THE NUMBER AND TYPES OF SCREENING PROGRAMS FOR EACH
TARGETED CANCER, BOTH STATEWIDE AND IN EACH COUNTY, AND THE NUMBER OF
PERSONS INDIVIDUALS SCREENED EACH YEAR IN THESE PROGRAMS;
(6) THE MECHANISMS TO INSURE THAT INDIVIDUALS WHO DO NOT
HAVE PRIVATE HEALTH INSURANCE AND ARE NOT COVERED BY MEDICAID OR
MEDICARE RECEIVE APPROPRIATE TREATMENT FOR ANY CANCER THAT IS
DETECTED IN A SCREENING PROGRAM; AND
(7) THE NUMBER OF IDENTIFIABLE CANCERS WITH A HIGH INCIDENCE
FOR WHICH THERE ARE:
(I) EFFECTIVE PROCEDURES FOR EARLY DETECTION; AND
(II) EFFECTIVE PROCEDURES FOR PREVENTION OR TREATMENT
AFTER EARLY DETECTION;
(8) ANY ASPECT OF TARGETED AND NONTARGETED CANCERS THAT THE
DEPARTMENT SEEKS TO MEASURE; AND
(7) (9) ANY OTHER FACTOR THAT THE DEPARTMENT DETERMINES TO
BE IMPORTANT FOR MEASURING RATES OF TARGETED CANCERS IN THE STATE OR
FOR EVALUATING WHETHER THE PROGRAM MEETS ITS OBJECTIVES.
(E) IN ORDER TO MAXIMIZE THE COST EFFECTIVENESS OF THE BASELINE
CANCER STUDY, THE DEPARTMENT MAY RELY ON DATA IN THE MARYLAND CANCER
REGISTRY OR PROVIDED BY OTHER SOURCES, TO THE EXTENT THAT THESE SOURCES
PROVIDE RELIABLE DATA RELATING TO THE FACTORS LISTED IN SUBSECTION (D) OF
THIS SECTION.
(F) (1) IF THE DEPARTMENT CHOOSES TO HAVE A HIGHER EDUCATION
INSTITUTION OR PRIVATE ENTITY CONDUCT THE BASELINE CANCER STUDY OR ANY
|
|
|
|
|
|
|
|
|
|
- 212 -
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
